BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9153298)

  • 1. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
    Di Cola G; Cool MH; Accili D
    J Clin Invest; 1997 May; 99(10):2538-44. PubMed ID: 9153298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
    Johansson GS; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
    Chisalita SI; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
    Rizk NN; Saed GM; Diamond MP
    Fertil Steril; 2006 Oct; 86(4 Suppl):1217-22. PubMed ID: 16962112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I/insulin hybrid receptors in human endothelial cells.
    Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.
    Federici M; Zucaro L; Porzio O; Massoud R; Borboni P; Lauro D; Sesti G
    J Clin Invest; 1996 Dec; 98(12):2887-93. PubMed ID: 8981937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor type-1 receptor down-regulation associated with dwarfism in Holstein calves.
    Blum JW; Elsasser TH; Greger DL; Wittenberg S; de Vries F; Distl O
    Domest Anim Endocrinol; 2007 Oct; 33(3):245-68. PubMed ID: 16829014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes.
    Bäck K; Arnqvist HJ
    Growth Horm IGF Res; 2009 Apr; 19(2):101-11. PubMed ID: 18693051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
    Chisalita SI; Nitert MD; Arnqvist HJ
    Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I.
    Escrivá F; González-Rodriguez A; Fernández-Millán E; Rondinone CM; Alvarez C; Valverde AM
    J Cell Physiol; 2010 Oct; 225(1):214-22. PubMed ID: 20506299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma.
    Chagnon MJ; Elchebly M; Uetani N; Dombrowski L; Cheng A; Mooney RA; Marette A; Tremblay ML
    Can J Physiol Pharmacol; 2006 Jul; 84(7):755-63. PubMed ID: 16998539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice.
    Masternak MM; Al-Regaiey KA; Del Rosario Lim MM; Jimenez-Ortega V; Panici JA; Bonkowski MS; Bartke A
    Exp Gerontol; 2005; 40(8-9):679-84. PubMed ID: 16054319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
    Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
    Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.